STDY News

National Commerce raised $33 million and then the Birmingham bank bounded. Two small medical device companies struggled as SteadyMed had a shaky opening and another pushed its IPO to next week. IPO highlights during the week of March 16, 2015: • Two IPOs: A successful bank offering and a struggling device company • This year's 29 IPOs now trade around their...read more

SteadyMed, which is developing a proprietary pump system for the treatment of PAH and pain, raised $40 million by offering 4.7 million shares at $8.50, below the range of $12 to $14. SteadyMed will list on the NASDAQ under the symbol STDY. Wells Fargo Securities and RBC Capital Markets acted as joint bookrunners on the deal....read more

Three IPOs are expected to price this week - a pump, a pump replacement and a regional bank - though the combined proceeds will still fall short of last week's single IPO. Get pumped for medical pumps SteadyMed (STDY) is...read more

SteadyMed, which is developing a combination therapy and pump for pulmonary disease and pain, announced terms for its IPO on Monday. The San Ramon, CA-based company plans to raise $55 million by offering 4.3 million shares at a price range of $12 to $14. At the midpoint of the proposed range, SteadyMed would command a fully diluted market value of $179 million. Another...read more